Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Non Operating Income (2018 - 2023)

Acro Biomedical (ACBM) has 6 years of Non Operating Income data on record, last reported at $789.0 in Q2 2023.

  • For Q2 2023, Non Operating Income rose 273.93% year-over-year to $789.0; the TTM value through Jun 2023 reached $2863.0, up 257.88%, while the annual FY2025 figure was $52878.0, 1318.67% up from the prior year.
  • Non Operating Income reached $789.0 in Q2 2023 per ACBM's latest filing, roughly flat from $788.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $8009.0 in Q4 2020 and bottomed at -$826.0 in Q3 2019.
  • Average Non Operating Income over 5 years is $866.89, with a median of $355.0 recorded in 2022.
  • The widest YoY moves for Non Operating Income: up 1920.23% in 2020, down 308.33% in 2020.
  • A 5-year view of Non Operating Income shows it stood at -$440.0 in 2019, then surged by 1920.23% to $8009.0 in 2020, then plummeted by 97.48% to $202.0 in 2021, then soared by 289.6% to $787.0 in 2022, then increased by 0.25% to $789.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $789.0 in Q2 2023, $788.0 in Q1 2023, and $787.0 in Q4 2022.